Bipolar Disorder CME: MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder: The France Foundation: White Plains, NY: October 22, 2008

• By MEASURE by The France Foundation
• Published 09/12/2008
• Psychiatry
• Rating: Unrated

MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder

MEASURE by The France Foundation

Now in it's sixth year, the objective of MEASURE is to provide psychiatrists and health care providers with a comprehensive continuing medical education program that will examine emerging clinical advances while addressing educational issues critical to improving the management of serious psychiatric disorders, including bipolar disorder.

Sign up to get personalized information from MEASURE by The France Foundation:
First Name:
Last Name:
Email:
Zip:
Specialty:
Select One Allergy Alternative Medicine Anesthesiology Biochemistry Cardiology Clinical Pharmacology Critical Care Dentistry Dermatology Diabetes Emergency Medicine Endocrinology Family Medicine Gastroenterology General Medicine Genetics Geriatrics Headache/Migraine Hematology Hepatology Immunology Infectious Disease Internal Medicine Medical/Business Practice Medical Ethics Multi-Speciality Physician/Practice Legal Nephrology Neurology Health Nutrition Obstetrics/Gynecology Oncology Opthalmology Orthopedics Osteopathy Otolaryngology Pathology Pain Management Pediatrics Plastic Surgery Podiatry Psychiatry Psychology Pulmonary Medicine Radiology Physician Assistants Respiratory Rheumatology Rural Medicine Sports Medicine Surgery Urology Nurse Practioner Nursing Vendor Other

View All Postings by This Contributor.

CME Sponsor: The France Foundation

Location:
Morton's, The Steakhouse
White Plains, NY

Course Directors/Instructors:
Robert M. Post, MD

Course Fee:
Free

Number of Credits:
1 AMA PRA Category 1

Link

Detailed Description:

The goal of the MEASURE Dinner Meetings is to provide psychiatrists with an interactive continuing medical education activity that addresses ongoing complex issues with the diagnosis and treatment of patients with bipolar disorder. Expert bipolar faculty deliver a lecture entitled "From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder" followed by a question/answer session.

For More Information
Call Toll Free: 1-866-856-1998  Fax: 1-860-434-5390

Learning Objectives:

• Describe neurophysiological findings and neurocognitive deficits in bipolar disorder and various phases of the illness
• Discuss how individual factors such as age, the presence of comorbidities, or ethnic/cultural issues impact the diagnosis and treatment of bipolar disorder
• Interpret emerging data from studies on bipolar disorder therapy
• Determine the appropriate strategies for multimodal combination therapies in the acute and long-term management of bipolar disorder

Spread The Word

• del.icio.us it
• Digg this
• Furl
• Reddit
• Yahoo! this!
• StumbleUpon
• Google Bookmarks
• Live Favorites
• Technorati

Comments

No Comments Found.

How would you rate the quality of this CME opportunity?
Rating: * Poor Excellent Your Name: Your Email: Your Comment: * Verification * Please copy the characters from the image above into the text field below. Doing this helps us prevent automated submissions.

This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.

CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.